FDA Approves TECNIS PureSee IOL for Cataract Surgery - Takeaways - MDSpire

FDA Approves TECNIS PureSee IOL for Cataract Surgery

First FDA-approved extended depth of focus (EDOF) IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL

Share

1

The FDA has approved the TECNIS PureSee IOL, an extended depth of focus intraocular lens for cataract surgery.
2

TECNIS PureSee IOL will be available to US patients later this year, enhancing vision restoration opportunities.
3

This IOL addresses cataract-related vision loss and presbyopia in a single surgical procedure.
4

It is the first FDA-approved EDOF IOL with no warning on loss of contrast sensitivity, maintaining visual clarity.
5

97% of patients report minimal visual disturbances post-surgery, reducing their reliance on glasses.